- Home
- INBX vs BRW Comparison
INBX vs BRW Comparison
Compare INBX & BRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- BRW
- Stock Information
- Founded
- INBX 2010
- BRW 1987
- Country
- INBX United States
- BRW United States
- Employees
- INBX N/A
- BRW N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- BRW Trusts Except Educational Religious and Charitable
- Sector
- INBX Health Care
- BRW Finance
- Exchange
- INBX Nasdaq
- BRW Nasdaq
- Market Cap
- INBX 345.8M
- BRW 355.1M
- IPO Year
- INBX 2020
- BRW N/A
- Fundamental
- Price
- INBX $26.54
- BRW $8.04
- Analyst Decision
- INBX Hold
- BRW
- Analyst Count
- INBX 2
- BRW 0
- Target Price
- INBX N/A
- BRW N/A
- AVG Volume (30 Days)
- INBX 112.9K
- BRW 222.1K
- Earning Date
- INBX 11-13-2025
- BRW 01-01-0001
- Dividend Yield
- INBX N/A
- BRW 15.59%
- EPS Growth
- INBX N/A
- BRW N/A
- EPS
- INBX N/A
- BRW N/A
- Revenue
- INBX $1,400,000.00
- BRW N/A
- Revenue This Year
- INBX N/A
- BRW N/A
- Revenue Next Year
- INBX N/A
- BRW N/A
- P/E Ratio
- INBX N/A
- BRW N/A
- Revenue Growth
- INBX N/A
- BRW N/A
- 52 Week Low
- INBX $10.81
- BRW $7.15
- 52 Week High
- INBX $30.23
- BRW $8.30
- Technical
- Relative Strength Index (RSI)
- INBX 52.65
- BRW 32.61
- Support Level
- INBX $27.51
- BRW $7.93
- Resistance Level
- INBX $28.86
- BRW $8.17
- Average True Range (ATR)
- INBX 1.38
- BRW 0.09
- MACD
- INBX -0.37
- BRW -0.03
- Stochastic Oscillator
- INBX 8.54
- BRW 25.00
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About BRW Saba Capital Income & Opportunities Fund SBI
Saba Capital Income & Opportunities Fund is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.